COVID-19: France grapples with the pragmatics of isolation

Laëtitia Atlani-Duault(Université Paris Cité), Jean-François Delfraissy(Agence Nationale de Recherches sur le Sida et les Hépatites Virales), Yazdan Yazdanpanah(Agence Nationale de Recherches sur le Sida et les Hépatites Virales), Franck Chauvin(Unknown), Bruno Lina(Université Claude Bernard Lyon 1), Denis Malvy(Université de Bordeaux)
The Lancet Public Health
October 10, 2020
10.1016/s2468-2667(20)30235-8
Cited by 14

Related Papers

Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k
High-Resolution Measurements of Face-to-Face Contact Patterns in a Primary School
|PLoS ONE|2011|857
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|714
Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
|The Lancet|1999|667